Open AccessOR16-2 Osilodrostat Treatment in Cushing's Disease (CD): Results from a Phase III, Multicenter, Double-Blind, Randomized Withdrawal Study (LINC 3)
Author(s) -
Beverly M. K. Biller,
John NewellPrice,
Maria Fleseriu,
Xavier Bertagna,
James W. Findling,
Akira Shimatsu,
Eun Jig Lee,
Feng Gu,
Richard Auchus,
Rattana Leelawattana,
André Lacroix,
Jung Hee Kim,
Audrey Laplanche,
Paul O’Connell,
Libuse Tauchmanovà,
Alberto M Pedroncelli,
Rosario Pivonello
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-or16-2
Subject(s) - medicine , tolerability , randomized controlled trial , randomization , placebo , clinical endpoint , population , adverse effect , gastroenterology , alternative medicine , environmental health , pathology